Overexpression of HER-2/neu in uterine serous papillary cancer.

Santin AD, Bellone S, Gokden M, Palmieri M, Dunn D, Agha J, Roman JJ, Hutchins L, Pecorelli S, O'Brien T, Cannon MJ, Parham GP. Overexpression of HER-2/neu in uterine serous papillary cancer. Clin Cancer Res. 2002 May; 8(5):1271-9.

View in: PubMed

subject areas

Aged
Antibodies, Monoclonal
Antineoplastic Agents
Breast Neoplasms
Cell Division
Cystadenocarcinoma, Papillary
Cystadenocarcinoma, Serous
Female
Flow Cytometry
Humans
Immunohistochemistry
Interleukin-2
Killer Cells, Natural
Middle Aged
Neoplasm Staging
Ovarian Neoplasms
Receptor, erbB-2
Tumor Cells, Cultured
Uterine Neoplasms

authors with profiles

Groesbeck Preer Parham, MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support